Day: January 7, 2019

Clinithink secures growth-equity investment to fuel growth

From Startup Clinithink Link to Full Article: https://clinithink.com/clinithink-secures-growth-equity/ Leading healthcare technology investors partner with Clinithink to unlock the potential of unstructured data to inform treatment decisions, identify candidates for clinical trials, and ensure appropriate reimbursement   Clinithink, which offers healthcare and life sciences organizations powerful clinical data insights through its

Sigilon Therapeutics and MIT Announce Research Collaboration to Advance Programmable Living Therapeutics for Serious Chronic Diseases

From Startup Sigilon Therapeutics Link to Full Article: http://sigilon.com/2019/01/07/sigilon-therapeutics-and-mit-announce-research-collaboration-to-advance-programmable-living-therapeutics-for-serious-chronic-diseases/ CAMBRIDGE, Mass. — January 7, 2019 — Sigilon Therapeutics, a biopharmaceutical company that discovers and develops Shielded Living Therapeutics, and the Massachusetts Institute of Technology today announced a strategic research collaboration. The collaboration leverages cutting-edge synthetic biology approaches developed by professor Ron Weiss

https://decibeltx.com/wp-content/uploads/2019/01/Decibel_Cocoon-Press-Release-Jan-7-2019-1.pdf

From Startup Decibal Therapeutics Decibel Therapeutics has established the world’s first comprehensive drug discovery, development, and translational research platform to discover and develop the first therapeutics to protect, repair, and restore hearing. To serve the over half billion people globally living with hearing loss and related disorders, Decibel is committed